- Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression
-
Sato S, Tamai Y
- KMID: 2507058
- Blood Res.
- 2020 Sep;55(3):175-177.
- doi: 10.5045/br.2020.2020045
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Identifying the link between multiple myeloma and neurofibromatosis type I
-
Rago A, Tordi A, Siniscalchi A, Andrizzi C, Campagna S, Toritto TCd
- KMID: 2507063
- Blood Res.
- 2020 Sep;55(3):187-189.
- doi: 10.5045/br.2020.2020102
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- An illustrative case of B-cell prolymphocytic leukemia
-
Jain A, Khunger J, Prasad P, Chaudhry S, Sharma M, Gupta DK, Saluja S
- KMID: 2507061
- Blood Res.
- 2020 Sep;55(3):181-184.
- doi: 10.5045/br.2020.2020079
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nuances in the management of acquired hemophilia A in an elderly patient with large granular lymphocytic leukemia
-
Tiwari NR, Chaudhari KS, Rao V, Sharma VR
- KMID: 2507060
- Blood Res.
- 2020 Sep;55(3):180-181.
- doi: 10.5045/br.2020.2020093
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation
-
Rieu JB, Largeaud L, Vergez F, Evrard S
- KMID: 2507051
- Blood Res.
- 2020 Sep;55(3):130-130.
- doi: 10.5045/br.2020.2020095
-
- CITED
-
- Close
- SHARE
-
- Close
- Peripheral blood histoplasmosis in an immunocompetent child with disseminated disease
-
Chauhan R, Pradhan S, Kotwal J, Chawla K, Kalra M, Sachdev A
- KMID: 2507050
- Blood Res.
- 2020 Sep;55(3):129-129.
- doi: 10.5045/br.2020.2020134
-
- CITED
-
- Close
- SHARE
-
- Close
- Hb-M Hyde Park: a rare cause of cyanosis arising from a de novo mutation
-
Rastogi L, Langer R, Radhakrishnan N, Saxena R, Kotwal J
- KMID: 2507059
- Blood Res.
- 2020 Sep;55(3):177-180.
- doi: 10.5045/br.2020.2020084
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia
-
Lee JW, Kim S, Jang PS, Chung NG, Cho B, Kim Y
- KMID: 2507062
- Blood Res.
- 2020 Sep;55(3):184-187.
- doi: 10.5045/br.2020.2020175
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of screening tools to differentiate beta thalassemia trait and iron-deficiency anemia - do they serve a purpose in blood donors?
-
Sundh A, Kaur P, Palta A, Kaur G
- KMID: 2507057
- Blood Res.
- 2020 Sep;55(3):169-174.
- doi: 10.5045/br.2020.2020219
Background The aim of this study was to estimate the prevalence of the beta thalassemia trait (BTT) and differentiate it from iron-deficiency anemia (IDA) among blood donors. Methods A total of 1,000 samples... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression
-
Srinivasan VK, Naseem S, Varma N, Lad DP, Malhotra P
- KMID: 2507052
- Blood Res.
- 2020 Sep;55(3):131-138.
- doi: 10.5045/br.2020.2020080
Background Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, which is attributed to differences in the genetic characteristics of the leukemic clone. We studied the genomic profile of 52 treatment-naïve CLL... -
- CITED
-
- Close
- SHARE
-
- Close
- Rare bleeding disorders: spectrum of disease and clinical manifestations in the Pakistani population
-
Mahmood R, Mahmood A, Khan M, Ali S, Khan SA, Jaffar SR
- KMID: 2507054
- Blood Res.
- 2020 Sep;55(3):146-150.
- doi: 10.5045/br.2020.2020035
Background Rare inherited coagulation factor deficiencies constitute an important group of bleeding disorders. A higher frequency of these disorders is seen in areas of high consanguinity. Our aim was to study the... -
- CITED
-
- Close
- SHARE
-
- Close
- KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute
-
Kim Y, Park SS, Min CK, Lee GD, Son J, Jo S, Han E, Han K, Kim M
- KMID: 2507056
- Blood Res.
- 2020 Sep;55(3):159-168.
- doi: 10.5045/br.2020.2020137
Background Plasma cell myeloma (PCM) is a genetically heterogeneous disease. The genetic spectrum of PCM has been expanded to mutations such as KRAS, NRAS, and BRAF genes in the RAS-RAF-MAPK pathway.... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation
-
Oh HJ, Hong SY, Jeong YM, Choi KS, Lee E, Lee E, Kim YJ, Bang SM
- KMID: 2507055
- Blood Res.
- 2020 Sep;55(3):151-158.
- doi: 10.5045/br.2020.2020056
Background Hematopoietic stem cell transplantation (HSCT) patients usually experience mucositis, musculoskeletal pain associated with high-dose chemotherapy, radiation, post-HSCT infection, or graft-versus-host disease. Pain management is important for the patients’ quality of... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
-
Gemelli M, Elli EM, Elena C, Iurlo A, Intermesoli T, Maffioli M, Pungolino E, Carraro MC, D’Adda M, Lunghi F, Anghileri M, Polverelli N, Rossi M, Bacciocchi M, Bono E, Bucelli C, Passamonti F, Antolini L, Gambacorti-Passerini C
- KMID: 2507053
- Blood Res.
- 2020 Sep;55(3):139-145.
- doi: 10.5045/br.2020.2020130
Background Generic formulations of imatinib mesylate have been introduced in Western Europe since 2017 to treat patients with chronic myeloid leukemia (CML). However, results on the safety and efficacy of generic... -
- CITED
-
- Close
- SHARE
-
- Close
